USD28.85
FDA Reverses Peptide Ban: BPC-157, GHK-Cu Back! ๐ The FDA has restored BPC-157, GHK-Cu, and 12 other crucial peptides to legal compounding status, effective 2026 under RFK Jr.'s HHS leadership. This means However, because there was a shortage of raw materials and the intracellular concentration of glutathione was not very high, the finished product was somewhat pricey, which hampered its ability to be put to practical use sickly https://m.media-amazon.com/images/I/71VXreeKUFL._AC_UL450_SY450_QL70_.jpg Volume:8
USD28.85
USD20.31
USD23.78
USD25.62